Three-year perinatal outcomes of less invasive beractant administration in preterm infants with respiratory distress syndrome
- 7 January 2019
- journal article
- research article
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 33 (16) , 2704-2710
Abstract
Objective: To assess the impact of beractant treatment using the less invasive surfactant administration (LISA) technique on perinatal outcomes in a prospective cohort of preterm infants with respiratory distress syndrome (RDS). RDS Design: Single-center prospective study conducted in a Department of Neonatology of a tertiary care university-affiliated hospital in Madrid, Spain. Methods: Preterm infants born at < 31 + 6 weeks’ gestation attended in the neonatal intensive care unit (NICU) between 2012 and 2016. The main outcome was the need of invasive mechanical ventilation during the first 3 days of life. Beractant (100 mg; 4 mL/kg) was administered using the intubation-surfactant-extubation (INSURE) method during 2012 and 2013, and using the LISA procedure between 2014 and 2016. Results: The study population included 512 infants, 232 in the first period and 280 in the second period. Mechanical ventilation exposure during hospitalization showed a significant reduction in the second study period, with an adjusted OR of 0.61, 95% CI 0.39–0.96. Also, an increase of free-bronchopulmonary dysplasia (BPD) survival was found (adjusted OR 2.14, 95% CI 1.29–3.55). These significant differences in perinatal outcomes were observed only in the group of infants of 26 + 0 to 28 + 6 gestational weeks. The success rate of the first dose of beractant using LISA regarding no need of intubation during the first 3 days of life was 54% increasing to 69% in the group of 26 + 0–28 + 6 weeks of gestation. The success rate regarding free-BPD survival was 63.5% in the whole series of LISA treated patients and 72.4% in the group of 26 + 0–28 + 6 weeks. Oxygen reduction after surfactant administration (OR 39.6, 95% CI 6.1–255.8, p < 0.001) was predictor of LISA success, whereas LISA failure was an independent factor for air leak (OR 18.92, 95% CI 1.31–272.32, p = 0.031) and Death or BPD outcome (OR 19.3, 95% IC 2.5–147.4, p = 0.004). Gestational age was inversely associated with the need of intubation after LISA (OR 0.53, 95% CI 0.32–0.87, p = 0.013). Conclusions: Beractant administration by LISA technique effective reduced the need of intubation during the first 3 days of life and was associated with an increase in survival-free BPD in the group of infants born at 26 + 0 and 28 + 6 weeks’ gestation.Keywords
This publication has 25 references indexed in Scilit:
- Comparative Effectiveness of Surfactant Preparations in Premature InfantsThe Journal of Pediatrics, 2013
- Poractant alfa versus beractant for respiratory distress syndrome in preterm infants: A retrospective cohort studyJournal of Paediatrics and Child Health, 2013
- Surfactant Administration via Thin Catheter During Spontaneous Breathing: Randomized Controlled TrialPediatrics, 2013
- Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trialThe Lancet, 2011
- Mortality in preterm infants with respiratory distress syndrome treated with poractant alfa, calfactant or beractant: a retrospective studyJournal of Perinatology, 2011
- Pharmacokinetics and clinical predictors of surfactant redosing in respiratory distress syndromeIntensive Care Medicine, 2010
- Bronchopulmonary DysplasiaAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Distribution of Exogenous Surfactant in Rabbits with Severe Respiratory Failure: The Effect of VolumePediatric Research, 1993
- The CRIB (clinical risk index for babies) score: a tool for assessing initial neonatal risk and comparing performance of neonatal intensive care unitsThe Lancet, 1993
- Progress in pathogenesis and management of clinical intraamniotic infectionAmerican Journal of Obstetrics and Gynecology, 1991